Health Care: Drugs

Impax Laboratories Inc. (IPXL: NASDAQ)

$18.71 -0.14 | -0.74%
06/19/13 - 12:24 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 581.69M 512.92M 879.51M 358.41M
Cost of Sales 210.17M 235.80M 218.92M 134.17M
Gross Operating Profit 371.52M 277.12M 660.58M 224.24M
Selling, General, and Administrative Expenses 118.24M 68.48M 53.33M 39.71M
Research & Development 81.32M 82.70M 86.22M 63.27M
Operating Income before D & A (EBITDA) 171.96M 125.94M 521.03M 121.26M
Depreciation & Amortization 88.96M 18.82M 121.32M 36.14M
Interest Income 1.09M 1.15M 1.04M 753.00K
Other Income - Net -138.00K -2.59M -315.00K 57.00K
Special Income / Charges 0.00 -7.51M -6.38M -14.70M
Total Income Before Interest Expenses (EBIT) 83.94M 98.17M 394.05M 71.22M
Interest Expense 632.00K 157.00K 167.00K 246.00K
Pre-Tax Income 83.31M 98.01M 393.88M 70.98M
Income Taxes 27.44M 32.62M 143.52M 21.01M
Minority Interest 0.00 -97.00K -60.00K -90.00K
Net Income From Continuing Operations 55.87M 65.50M 250.42M 50.06M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 55.87M 65.50M 250.42M 50.06M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 55.87M 65.50M 250.42M 50.06M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 55.87M 73.00M 256.80M 64.76M
Preferred Dividends
Net Income Available To Common 55.87M 65.50M 250.42M 50.06M
Basic EPS from Continuing Ops. 0.85 1.02 4.04 0.83
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.85 1.02 4.04 0.83
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.85 1.02 4.04 0.83
Basic Normalized Net Income/Share 0.85 1.14 4.14 1.07
EPS fr Continuing Ops. 0.82 0.97 3.82 0.82
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.82 0.97 3.82 0.82
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.82 0.97 3.82 0.82
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 0.82 1.08 3.92 1.06
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IPXL

View All

Latest IPXL Headlines from TheStreet

More Financial News for IPXL

Press Releases for IPXL

See All Press Releases

Partner Headlines for IPXL

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter